Brand-Name, Generic Reglan Makers Beat Injury Suit

Law360, New York (September 28, 2012, 7:51 PM EDT) -- An Ohio federal judge ruled Thursday that neither brand-name nor generic makers of the anti-heartburn medication Reglan can be held liable in a woman's suit linking her neurological disorder to generic Reglan, since brand-name companies did not make the products and claims against the generics companies are preempted by federal law.

U.S. District Judge Michael Watson granted summary judgment motions from brand-name defendants Pfizer Inc., Pfizer unit Wyeth LLC and Schwarz Pharma, now known as UCB Inc., and a motion for judgment on the pleadings from...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Hogue et al v. Pfizer, Inc. et al


Case Number

2:10-cv-00805

Court

Ohio Southern

Nature of Suit

Personal Inj. Prod. Liability

Judge

Michael H. Watson

Date Filed

September 9, 2010

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.